The sample consisted of 52 post-COVID-19 patients (51.9% female, 41.8% male) with a mean age of 34.2 (min=19.0, max=34.2, std=11.6) and a mean IL-6 of 1.40 in the V- group and 1.93 in the V+ group (Table 1). An independent samples t-test was performed between the two groups of V+ and V- patients and IL-6 levels. This evidence concerns the gene IL6 and COVID-19.